Sr Associate Scientist - Thousand Oaks, CA | Biospace
Get Our FREE Industry eNewsletter

Sr Associate Scientist

Amgen

Apply
Location:
Thousand Oaks, CA
Posted Date:
8/22/2017
Position Type:
Full time
Job Code:
R-42191
Salary:
Required Education:
Masters Degree
Areas of Expertise Desired:

Job Description

We are seeking a Senior Associate Scientist to be one of the leading scientists in Amgen's cardiometabolic disorders group engaged in pharmacological studies and drug development related to cardiac arrhythmias.

Responsibilities:

The Senior Associate will interact seamlessly and collaboratively with project leaders in cardiometabolic and other therapeutic areas to help guide efforts to discover novel therapeutics.

Establish pre-clinical electrophysiological techniques to measure monophasic action potentials and 12-lead pseudo Electrocardiogram (ECG) in the laboratory and to support the laboratory manager in developing new assays, interpret and present data.

Help the team in preparing high quality scientific publications as well as research reports for internal teams and external agencies

Requirements

Basic Qualifications:

Master's degree and 3 years of scientific experience

OR

Bachelor's degree and 5 years of scientific experience

Preferred Qualifications:

Master's degree and 5+ years in Life Sciences, Pharmacology, or Scientific discipline

Deep content expertise in the cellular biology and physiology of cardiovascular disease.

Experience in establishing preclinical models for cardiac arrhythmias.

In-vitro, ex-vivo and in-vivo experimental/electrophysiological experience in academia or industrial setting.

Strong verbal and written communication skills, and be able to function optimally in a team-based/collaborative environment

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.